DNA damage in human whole blood caused by radiopharmaceuticals evaluated by the comet assay.
- Published in:
- Mutagenesis, 2019, v. 34, n. 3, p. 239, doi. 10.1093/mutage/gez007
- By:
- Publication type:
- Article
Works matching IS 02678357 AND DT 2019 AND VI 34 AND IP 3
Results: 7
1
2
Inclusion of an extended treatment with recovery improves the results for the human peripheral blood lymphocyte micronucleus assay.
- Published in:
- Mutagenesis, 2019, v. 34, n. 3, p. 217, doi. 10.1093/mutage/gez011
- By:
- Publication type:
- Article
3
Quantitative analysis of mutagenicity and carcinogenicity of 2-amino-3-methylimidazo[4,5-f]quinoline in F344 gpt delta transgenic rats.
- Published in:
- Mutagenesis, 2019, v. 34, n. 3, p. 279, doi. 10.1093/mutage/gez015
- By:
- Publication type:
- Article
4
The repeated cytogenetic analysis of subjects occupationally exposed to nanoparticles: a pilot study.
- Published in:
- Mutagenesis, 2019, v. 34, n. 3, p. 253, doi. 10.1093/mutage/gez016
- By:
- Publication type:
- Article
5
ZnO nanoparticles-associated mitochondrial stress-induced apoptosis and G2/M arrest in HaCaT cells: a mechanistic approach.
- Published in:
- Mutagenesis, 2019, v. 34, n. 3, p. 265, doi. 10.1093/mutage/gez017
- By:
- Publication type:
- Article
6
Analysis of basal chromosome instability in patients with chronic lymphocytic leukaemia.
- Published in:
- Mutagenesis, 2019, v. 34, n. 3, p. 245, doi. 10.1093/mutage/gez009
- By:
- Publication type:
- Article
7
Response of Sulfolobus solfataricus Dpo4 polymerase in vitro to a DNA G-quadruplex.
- Published in:
- Mutagenesis, 2019, v. 34, n. 3, p. 289, doi. 10.1093/mutage/gez010
- By:
- Publication type:
- Article